RPG Ventures
Mumbai, India10
7M
7
1
0.30
1
- Areas of investment
Investor highlights
- Industry generalist
- Yes
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 10
- Lead investments
- 1
- Exits
- 1
- Follow on index
- 0.30
- Investments by industry
- Internet (6)
- E-Commerce (5)
- Agriculture (3)
- Communities (3)
- Information Technology (2) Show 16 more
- Investments by region
- India (9)
- United States (1)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 0.90
- Avg. company exit year
- 6
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| sentra.world | 05 Jun 2023 | SaaS, Industrial | Seed | 2M | Bangalore, Karnataka, India |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| EnsiliTech | Aug 28, 2025 | Biopharmaceuticals, Biotechnology, Ensilication, Ensilication technology, Refrigeration-free transport | - | 4500000 GBP |  Bristol, England |
| Naturbeads | Nov 14, 2024 | Adhesive, Biodegradable Ingredients, Cosmetic and Personal Care Products, Industrial Applications, Packaging, Paints and Coating, Sustainable Ingredients | Early stage | 7800000 GBP | Bath, England |
| Chromacity | Aug 5, 2024 | Agriculture, Healthcare, Industrial Research, Laser Technology, Quantum Applications, Scientific Research | - | 1000000 GBP | Edinburgh, Scotland |
| Cumulus Oncology | Aug 1, 2024 | AI, Artificial Intelligence, Biotech, Machine Learning, Molecularly Selected Patient Sub-Groups, Oncology | Early stage | 9000000 GBP | Edinburgh, Scotland |
| Neupulse | Mar 18, 2024 | Brain Imaging, Brain Stimulation, Health Tech, Medical Device, Non-drug treatment, Non-Drug Treatment, Wearable Device | Early stage | 3200000 USD | Nottingham, England |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.